agilon health, inc.
AGL
$3.51
-$0.02-0.57%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.94% | -2.15% | |||
| Total Other Revenue | 0.22% | 1.76% | |||
| Total Revenue | 4.93% | -2.15% | |||
| Cost of Revenue | 3.01% | 4.45% | |||
| Gross Profit | 40.38% | -299.43% | |||
| SG&A Expenses | -2.85% | -10.29% | |||
| Depreciation & Amortization | 4.44% | 5.26% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.79% | 3.79% | |||
| Operating Income | 20.74% | -210.89% | |||
| Income Before Tax | 10.55% | -286.91% | |||
| Income Tax Expenses | 397.80% | -241.49% | |||
| Earnings from Continuing Operations | 8.59% | -279.73% | |||
| Earnings from Discontinued Operations | 154.10% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 10.05% | -283.34% | |||
| EBIT | 20.74% | -210.89% | |||
| EBITDA | 21.99% | -244.11% | |||
| EPS Basic | 10.18% | -283.11% | |||
| Normalized Basic EPS | 12.48% | -292.62% | |||
| EPS Diluted | 11.88% | -292.63% | |||
| Normalized Diluted EPS | 12.48% | -292.62% | |||
| Average Basic Shares Outstanding | 0.11% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.11% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
